Investigation Report on China Ezetimibe Market, 2010-2019
|出版商||China Research and Intelligence||商品編碼||332771|
|出版日期||內容資訊||英文 20 Pages
|Ezetimibe的中國市場分析 (2010∼2019年) Investigation Report on China Ezetimibe Market, 2010-2019|
|出版日期: 2015年06月11日||內容資訊: 英文 20 Pages||
隨著經濟發展和生活水準的上升，中國高血脂症的患者劇增，降膽固醇藥物的需求也急速擴大。Ezetimibe是全球第一個膽固醇吸收選擇的材料劑，2002年取得FDA (美國食品藥物管理局) 的認證。中國2007年為67萬人民幣的市場規模之後也以137％年複合成長率(CAGR) 急速成長，到2014年達到2億67萬人民幣。
With the sustained economic development and the improvements in diet, Chinese people's blood fat level rises too. Many local epidemiological studies on blood fat have proved that a conservative estimate of the incidence of hyperlipemia is 7%-8% while the actual incidence might be above 10%. Over 100 million people in China have to receive cholesterol-lowering therapy, more so with the coming ageing society. As people increasingly pay attention to health, cholesterol-lowering drugs will become more and more promising. The annual market size of statin drug is estimated to surpass USD 20 billion around the world, growing at an annual rate of 20% .
Ezetimibe, the first cholesterol absorption selective inhibitor in the world, was jointly developed by Merck and Schering-Plough and approved by FDA in 2002 as the first drug for regulating blood fat with completely innovative mechanism of action after statin. Ezetimibe can selectively inhibit cholesterol transporter in the small intestine, effectively reduce cholesterol absorption, lower plasma cholesterol level and decrease the amount of cholesterol normally available to liver cells. As an ideal partner of statin, ezetimibe can provide better control rates for LDL-C with good safety and tolerance than doubled statin dose or more potent statin.
Ezetimibe in the Chinese market is monopolized by Schering-Plough. Ezetimibe develops fast after entering China with annual sales rising from less than CNY 0.05 million in 2007 to CNY 20.67 million in 2014 and CAGR during this period reaching up to 137%.
Ezetimibe enjoys a vast demand in China and its market size is expected to grow in the next few years.
Readers can get at least the following information from this report:
The author suggests the following groups of people purchase this report: